HeliTrax FAQ Contact Us Forward to a Friend

Hemophilia Information Resources

Helixate^® FS is backed by CSL Behring’s long commitment to the patient community.

Find a hemophilia treatment center (HTC), or chapter near you.

Access a glossary of hemophilia terms, or learn more about the many other programs and support services offered.

Also be sure to visit HemophiliaMoms.com to access more resources and read real stories from moms raising kids with hemophilia.

AllAboutBleeding-US.com is an online resource dedicated to increasing awareness about hemophilia. You'll find information about hemophilia, a community of people sharing their experiences, plus an expert to answer questions about hemophilia. Visit AllAboutBleeding-US.com

Find helpful resources such as billing codes for Helixate^® FS or locate a Helixate^® FS representative near you.

There are plenty of questions about hemophilia. Find answers to many of them here.

Reach out to find other resources near you. Find your local hemophilia chapter or treatment center.

Important Safety Information

Helixate^® FS, Antihemophilic Factor (Recombinant), is a recombinant factor VIII treatment indicated for the control and prevention of bleeding episodes and peri-operative management in adults and children (0-16 years) with hemophilia A. Helixate^® FS is also indicated for routine prophylaxis to reduce the frequency of bleeding episodes and the risk of joint damage in children with hemophilia A with no preexisting joint damage.

The most serious adverse reactions are systemic hypersensitivity reactions and the development of high-titer inhibitors necessitating alternative treatments to antihemophilic factor. The most common adverse reactions observed in clinical trials were inhibitor formation in previously untreated or minimally treated patients, skin-associated hypersensitivity reactions, infusion site reactions, and central venous access device (CVAD) line-associated infections.

Helixate^® FS is contraindicated in patients who have manifested life-threatening immediate hypersensitivity reactions, including anaphylaxis, to the product or its components, including mouse or hamster proteins.

Please see the full prescribing information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.